104 related articles for article (PubMed ID: 16011526)
1. New drugs.
Waters L; Nelson MR
HIV Med; 2005 Jul; 6(4):225-31. PubMed ID: 16011526
[No Abstract] [Full Text] [Related]
2. A lame duck, a dark horse, and a goat.
Huff B
GMHC Treat Issues; 2005; 19(5-6):4-5. PubMed ID: 16193576
[No Abstract] [Full Text] [Related]
3. New nucleoside reverse transcriptase inhibitors for the treatment of HIV infections.
Otto MJ
Curr Opin Pharmacol; 2004 Oct; 4(5):431-6. PubMed ID: 15351346
[TBL] [Abstract][Full Text] [Related]
4. New treatment options for HIV salvage patients: an overview of second generation PIs, NNRTIs, integrase inhibitors and CCR5 antagonists.
Hughes A; Barber T; Nelson M
J Infect; 2008 Jul; 57(1):1-10. PubMed ID: 18556070
[TBL] [Abstract][Full Text] [Related]
5. New protease inhibitors and non-nucleoside reverse transcriptase inhibitors.
Lascar M; Cartledge JD
J HIV Ther; 2008 Jun; 13(2):40-4. PubMed ID: 18953273
[No Abstract] [Full Text] [Related]
6. Meeting notes from the 3rd IAS Conference. New drugs.
Feinberg J
AIDS Clin Care; 2005 Oct; 17(10):96-7. PubMed ID: 16276591
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and mechanistic basis for the activity of nucleoside analogue inhibitors of HIV reverse transcriptase.
Painter GR; Almond MR; Mao S; Liotta DC
Curr Top Med Chem; 2004; 4(10):1035-44. PubMed ID: 15193137
[TBL] [Abstract][Full Text] [Related]
8. New antiretroviral agents.
Gallant JE
Hopkins HIV Rep; 2001 Mar; 13(2):2, 16. PubMed ID: 12184261
[No Abstract] [Full Text] [Related]
9. Darunavir-etravirine-raltegravir as salvage combination therapy in a heavily pretreated HIV-infected patient.
Vento S; Vallone A
AIDS Patient Care STDS; 2008 Nov; 22(11):841-2. PubMed ID: 19025477
[No Abstract] [Full Text] [Related]
10. When and how to use tipranavir and darunavir.
Hoffman CJ; Gallant JE
AIDS Read; 2007 Apr; 17(4):194-8, 201. PubMed ID: 17479503
[No Abstract] [Full Text] [Related]
11. New non-nucleoside reverse transcriptase inhibitors (NNRTIs) in development for the treatment of HIV infections.
Pauwels R
Curr Opin Pharmacol; 2004 Oct; 4(5):437-46. PubMed ID: 15351347
[TBL] [Abstract][Full Text] [Related]
12. New drugs.
Pozniak A
J HIV Ther; 2008 Jun; 13(2):27-33. PubMed ID: 18953271
[No Abstract] [Full Text] [Related]
13. Elvucitabine data released at CROI.
AIDS Patient Care STDS; 2010 Mar; 24(3):198. PubMed ID: 20235383
[No Abstract] [Full Text] [Related]
14. Antiretrovirals, Part II: focus on non-protease inhibitor antiretrovirals (NRTIs, NNRTIs, and fusion inhibitors).
Zapor MJ; Cozza KL; Wynn GH; Wortmann GW; Armstrong SC
Psychosomatics; 2004; 45(6):524-35. PubMed ID: 15546830
[TBL] [Abstract][Full Text] [Related]
15. Lipid-lowering effect and efficacy after switching to etravirine in HIV-infected patients with intolerance to suppressive HAART.
Casado JL; de Los Santos I; Del Palacio M; García-Fraile L; Pérez-Elías MJ; Sanz J; Moreno S
HIV Clin Trials; 2013; 14(1):1-9. PubMed ID: 23372109
[TBL] [Abstract][Full Text] [Related]
16. [Introduction. Etravirine: a new standard of potency and safety among non-nucleoside analogues].
Domingo P
Enferm Infecc Microbiol Clin; 2009 Dec; 27 Suppl 2():1. PubMed ID: 20116620
[No Abstract] [Full Text] [Related]
17. Meeting notes from ICAAC. D-D4FC (Reverset): further data on treatment-experienced patients.
Sax PE
AIDS Clin Care; 2005 Jan; 17(1):8. PubMed ID: 15717377
[No Abstract] [Full Text] [Related]
18. Etravirine(Intelence) for HIV infection.
Med Lett Drugs Ther; 2008 Jun; 50(1288):47-8. PubMed ID: 18551091
[No Abstract] [Full Text] [Related]
19. [Protease inhibitor or non-nucleoside reverse transcriptase inhibitor. ACTG study 5202 in focus].
MMW Fortschr Med; 2010 Apr; 152(17):68-9. PubMed ID: 20509268
[No Abstract] [Full Text] [Related]
20. Potent antiviral effect of reverset in HIV-1-infected adults following a single oral dose.
Stuyver LJ; McBrayer TR; Schürmann D; Kravec I; Beard A; Cartee L; Schinazi RF; De La Rosa A; Murphy RL; Otto MJ
Antivir Ther; 2004 Aug; 9(4):529-36. PubMed ID: 15456084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
